Price Target Intelligence
Latest FMP target revisions, largest changes and implied upside.
Limited daily previewLast updated 5 hrs ago
Analyst Intelligence3 sample rows visible. INVESTOR unlocks all data.
View pricing0Target Raises Today0 raises in loaded feed
0Target Cuts Today0 cuts in loaded feed
+26.8%Average Target UpsidePublished targets vs. current price
0Stocks With Rising Targets0% of 8 covered tickers
Largest Target Increases
No linked target raises.
Largest Target Cuts
No linked target cuts.
Highest Upside
Published target vs. current price
Highest Downside
Targets below current price
No published targets below price.
Most Active Stocks
Target events per ticker
Target Changes Trend
Raises vs cuts by reported date
Not enough reported data to chart.
All Price Target Changes
8 reported events · click a column to sortTarget RaisedBuy→Buy
Price$18.96
Target$22Prior target not reported
Upside+16.0%
OCOliver Chen · Cowen & Co.
Source: Sally Beauty Holdings (SBH) PT Raised to $22 at TD CowenTarget CutBuy→Buy
Price$111.60
Target$137Prior target not reported
Upside+22.8%
C&Analyst not provided · Cowen & Co.
Source: Twist Bioscience (TWST) PT Lowered to $137 at TD CowenTarget RaisedBuy→Buy
Price$275.39
Target$352Prior target not reported
Upside+27.8%
C&Analyst not provided · Cowen & Co.
Source: Ascendis Pharma (ASND) PT Raised to $352 at TD CowenTarget RaisedOutperform→Outperform
Price$10.32
Target$14Prior target not reported
Upside+35.7%
MSMatthew Swanson · RBC Capital
Source: Nexxen (NEXN) PT Raised to $14 at RBC CapitalTarget CutOutperform→Outperform
Price$9.43
Target$11Prior target not reported
Upside+16.6%
AVArun Viswanathan · RBC Capital
Source: Corteva Inc. (CTVA) PT Lowered to $11 at RBC CapitalTarget CutOutperform→Outperform
Price$40.97
Target$59Prior target not reported
Upside+44.0%
BDBart Dziarski · RBC Capital
Source: Brookfield Corporation (BN) PT Lowered to $59 at RBC CapitalTarget CutOutperform→Outperform
Price$89.35
Target$106Prior target not reported
Upside+18.6%
BAnalyst not provided · Bernstein
Source: CVS Health (CVS) PT Lowered to $106 at Bernstein SocGen GroupTarget RaisedBuy→Buy
Price$24.89
Target$33Prior target not reported
Upside+32.6%
MSMauricio Serna · UBS
Source: Wolverine World Wide (WWW) PT Raised to $33 at UBS Amid Industry-Wide Promotional Pressures SBH | Sally Beauty Holdings, Inc. | Cowen & Co. | Target not reported | $22 | — | $18.96 | +16.0% | 13 / 11 / 2026 |
 TWST | Twist Bioscience Corporation | Cowen & Co. | Target not reported | $137 | — | $111.60 | +22.8% | 13 / 11 / 2026 |
 ASND | Ascendis Pharma A/S | Cowen & Co. | Target not reported | $352 | — | $275.39 | +27.8% | 13 / 11 / 2026 |
 NEXN | Nexxen International Ltd. | RBC Capital | Target not reported | $14 | — | $10.32 | +35.7% | 13 / 11 / 2026 |
 CTVA | Corteva, Inc. | RBC Capital | Target not reported | $11 | — | $9.43 | +16.6% | 13 / 11 / 2026 |
 BN | Brookfield Corporation | RBC Capital | Target not reported | $59 | — | $40.97 | +44.0% | 13 / 11 / 2026 |
 CVS | CVS Health Corp. | Bernstein | Target not reported | $106 | — | $89.35 | +18.6% | 13 / 11 / 2026 |
 WWW | Wolverine World Wide, Inc. | UBS | Target not reported | $33 | — | $24.89 | +32.6% | 13 / 11 / 2026 |
1–8 of 8
1 / 1